Analystreport

Wave Life Sciences Ltd (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at Zacks Investment Research. They now have a $9.25 price target on the stock.

Wave Life Sciences Ltd. - Ordinary Shares  (WVE) 
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am Check Earnings Report